Surrogate endpoints in clinical trials: cardiovascular diseases.
暂无分享,去创建一个
[1] A. Moss,et al. Survivorship patterns in the posthospital phase of myocardial infarction. , 1979, Circulation.
[2] H. Harlow,et al. Affectional responses in the infant monkey; orphaned baby monkeys develop a strong and persistent attachment to inanimate surrogate mothers. , 1959, Science.
[3] E. Ford,et al. In-hospital mortality rates from acute myocardial infarction by race in U.S. hospitals: findings from the National Hospital Discharge Survey. , 1987, Circulation.
[4] R. Collins,et al. Intravenous and intracoronary fibrinolytic therapy in acute myocardial infarction: overview of results on mortality, reinfarction and side-effects from 33 randomized controlled trials. , 1985, European heart journal.
[5] D H Blankenhorn,et al. Beneficial effects of combined colestipol-niacin therapy on coronary atherosclerosis and coronary venous bypass grafts. , 1987, JAMA.
[6] Stephen L. George,et al. Fundamentals of Clinical Trials. (2nd ed.). , 1987 .